GI Videos

Scott Kopetz, MD, PhD, FACP, discusses using targeted therapy earlier in the treatment of patients with CRC and BRAF V600E mutation.

Rachel Riechelmann, MD, PhD, gives an update on what's new in gastrointestinal and pancreatic NETs in the past year.

David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.

Andrés Cervantes, MD, PhD, discusses new therapeutic agents for advanced gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.

In this 3-part video series, Dr Ilson discusses the current adjuvant treatment landscape for patients with gastric cancer.

At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed the role of cabozantinib in the second-line HCC therapy.

At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the role of pre-surgery chemotherapy in pancreatic cancer.

Eric Van Cutsem, MD, PhD, talks about what attendees of World GI can anticipate at this year's meeting in Barcelona, Spain, July 3-6, 2019.

At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed how to best sequence drugs in the treatment of HCC.